Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68) - Image 1

£179.99

Springer Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Name: Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
Brand: Springer
Price: 179.99 GBP
Availability: InStock

Infectious & Contagious Diseases

Price History & Forecast

Last 75 days • 75 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 75 days • 1 price levels

Days at Price

Price Analysis

Most common price: £180 (75 days, 100.0%)

Price range: £180 - £180

Price levels: 1 different prices over 75 days

Description

The hybridoma technique for producing monoclonal antibodies developed by Drs. Kohler and Millstein in 1975 revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value, and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of Cancer Treatment and Research explores the current state of the art of immunoconjugate therapy of hematologic malignancies. The first chapter, authored by Drs. Rosen and Kuzel, reviews the current status of radioimmunotherapy of lymphoma. Results of clinical investigations utilizing radiolabeled immunoconjugates in B-cell lymphomas, T-cell lym phomas, and Hodgkin's disease are discussed. In addition, obstacles to effective antibody therapy are highlighted and toxicities are summarized. Chapter 2, written by Drs. Sgouros and Scheinberg, critiques the treat ment of leukemia with radiolabeled monoclonal antibodies. In this chapter, the unique features of leukemia that make it particularly suitable for radio immunotherapy are discussed, an overview of selected clinical trials is presented, and a treatment planning approach to radioimmunotherapy in corporating biologic and physical parameters is reviewed.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0792322703
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 30 September 1993
Listed Since: 15 December 2006

Barcode

No barcode data available

Springer Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Radiation Oncology and Radiotherapy Part B (Volume 174) (Methods in Cell Biology, Volume 174)

Critical Developments in Cancer Immunotherapy

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Infection Management in Hematology (Hematologic Malignancies)

Aktuelle Therapie bösartiger Blutkrankheiten

Etiology of Acute Leukemias in Children

The Bethesda Handbook of Clinical Oncology

Oncologic Therapies

Novel Developments in Stem Cell Mobilization: Focus on CXCR4

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research)

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Pocket Oncology (Pocket Notebook Series)

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Clinical Applications of Nuclear Medicine Targeted Therapy

Induction Chemotherapy: Systemic and Locoregional

Circulating Tumor Cells: Methods and Protocols: 1634 (Methods in Molecular Biology, 1634)

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Cell Reprogramming for Immunotherapy: Methods and Protocols: 2097 (Methods in Molecular Biology, 2097)